Manufacturing

Joy Aho is the senior project manager for Be The Match BioTherapies.

Articles

Taking key considerations into account along the cell therapy supply chain can set cell therapy developers up for success.

Reducing Risk: Establishing Consistency and Scalability of Cell Therapy Starting Material

Symbiosis announced the successful completion of UK Research and Innovation project to enhance the manufacturing supply chain for ATMPs within the UK.

Symbiosis Successfully Completes UK Research and Innovation Project to Enhance Supply Chain for ATMPs

New report released by USP offers a look into API supply-chain vulnerabilities.

USP Medicine Supply Map Reviews Global API Manufacturing 

Susan Haigney is managing editor of BioPharm International, susan.haigney@ubm.com.

Disruptions in the bio/pharmaceutical supply chain can have serious impacts on the quality and availability of life-saving medicines.

Supply Chain Considerations for Ensuring Quality

Tracy Nasarenko is senior director Community Engagement, GS1 US.

Interoperability by 2023 depends on data standardization and systems compatibility between trading partners.

DSCSA’s Next Big Hurdle

 Washington Editor, jillwechsler7@gmail.com.

Biotech companies and medical product manufacturers have condemned the invasion of Ukraine, while also looking to maintain supplies of essential medicines.

Ukraine Invasion Challenges Biopharma Research and Operations

Thermo Fisher Scientific's solution for cell and gene therapies involves a combination of cold chain logistics, serialization compliance, and distribution 

Thermo Fisher Scientific Unveils New CGT Services

Lighthouse manufacturing techniques utilize technology and automation to streamline production.

The Lighthouse Effect: Using Technology to Improve Life Sciences Manufacturing

Feliza Mirasol is the science editor for 

New and emerging biotherapeutic molecules drive the need for innovative solutions to meet cold-chain requirements.

Finding Solutions to Cold Chain Supply

Moderna’s agreement with the UK government includes 29 million COVID-19 vaccine doses for delivery in 2022 and 31 million doses for delivery in 2023.

Supply Chain/Logistics